Ig gene analysis reveals altered selective pressures on ig-producing cells in parotid glands of primary Sjögren's syndrome patients

Journal of Immunology

Volumn 194, Issue 2, 2015, Pages 514-521

  Hamza, Nishath ^a   Hershberg, Uri ^b   Kallenberg, Cees G M ^a   Vissink, Arjan ^a   Spijkervet, Frederik K L ^a   Bootsma, Hendrika ^a   Kroese, Frans G M ^a   Bos, Nicolaas A ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^b DREXEL UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

B LYMPHOCYTE RECEPTOR; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; LECTIN; IMMUNOGLOBULIN HEAVY CHAIN; IMMUNOGLOBULIN VARIABLE REGION;

ADULT; AGED; ANTIGEN SPECIFICITY; ARTICLE; B LYMPHOCYTE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GENE; GENE SEQUENCE; GENETIC ANALYSIS; HUMAN; HUMAN TISSUE; IGHV3 GENE; IMMUNOGLOBULIN PRODUCING CELL; LYMPHOCYTE PROLIFERATION; MICROENVIRONMENT; NUCLEOTIDE SEQUENCE; PAROTID GLAND; SALIVARY GLAND BIOPSY; SJOEGREN SYNDROME; SOMATIC HYPERMUTATION; UNINDEXED SEQUENCE; CELL PROLIFERATION; CLINICAL TRIAL; GENETICS; IMMUNOGLOBULIN VARIABLE REGION; IMMUNOLOGY; MIDDLE AGED; MOLECULAR GENETICS; PATHOLOGY;

ADULT; AGED; BASE SEQUENCE; CELL PROLIFERATION; FEMALE; HUMANS; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN HEAVY CHAINS; IMMUNOGLOBULIN VARIABLE REGION; MIDDLE AGED; MOLECULAR SEQUENCE DATA; PAROTID GLAND; SJOGREN'S SYNDROME;

EID: 84920494935     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1302644     Document Type: Article

References (50)

1. Fox, R. I. 2005. Sjögren's syndrome. Lancet 366: 321-331.
2. Jonsson, M. V., K. Skarstein, R. Jonsson, and J. G. Brun. 2007. Serological implications of germinal center-like structures in primary Sjögren's syndrome. J. Rheumatol. 34: 2044-2049.
3. Theander, E., L. Vasaitis, E. Baecklund, G. Nordmark, G. Warfvinge, R. Liedholm, K. Brokstad, R. Jonsson, and M. V. Jonsson. 2011. Lymphoid organisation in labial salivary gland biopsies is a possible predictor for the development of malignant lymphoma in primary Sjögren's syndrome. Ann. Rheum. Dis. 70: 1363-1368.
4. Hernández-Molina, G., G. Leal-Alegre, and M. Michel-Peregrina. 2011. The meaning of anti-Ro and anti-La antibodies in primary Sjögren's syndrome. Autoimmun. Rev. 10: 123-125.
5. Pollard, R. P., J. Pijpe, H. Bootsma, F. K. Spijkervet, P. M. Kluin, J. L. Roodenburg, C. G. Kallenberg, A. Vissink, and G. W. van Imhoff. 2011. Treatment of mucosa-associated lymphoid tissue lymphoma in Sjögren's syndrome: A retrospective clinical study. J. Rheumatol. 38: 2198-2208.
6. Dass, S., S. J. Bowman, E. M. Vital, K. Ikeda, C. T. Pease, J. Hamburger, A. Richards, S. Rauz, and P. Emery. 2008. Reduction of fatigue in Sjögren syndrome with rituximab: results of a randomised, double-blind, placebocontrolled pilot study. Ann. Rheum. Dis. 67: 1541-1544.
7. Meijer, J. M., P. M. Meiners, A. Vissink, F. K. Spijkervet, W. Abdulahad, N. Kamminga, E. Brouwer, C. G. Kallenberg, and H. Bootsma. 2010. Effectiveness of rituximab treatment in primary Sjögren's syndrome: A randomized, double-blind, placebo-controlled trial. Arthritis Rheum. 62: 960-968.
8. Abdulahad, W. H., J. M. Meijer, F. G. Kroese, P. M. Meiners, A. Vissink, F. K. Spijkervet, C. G. Kallenberg, and H. Bootsma. 2011. B cell reconstitution and T helper cell balance after rituximab treatment of active primary Sjögren's syndrome: A double-blind, placebo-controlled study. Arthritis Rheum. 63: 1116-1123.
9. Chang, B., and P. Casali. 1994. The CDR1 sequences of a major proportion of human germline Ig VH genes are inherently susceptible to amino acid replacement. Immunol. Today 15: 367-373.
10. Lossos, I. S., R. Tibshirani, B. Narasimhan, and R. Levy. 2000. The inference of antigen selection on Ig genes. J. Immunol. 165: 5122-5126.
11. Uduman, M., G. Yaari, U. Hershberg, J. A. Stern, M. J. Shlomchik, and S. H. Kleinstein. 2011. Detecting selection in immunoglobulin sequences. Nucleic Acids Res. 39: W99-W504.
12. Yaari, G., M. Uduman, and S. H. Kleinstein. 2012. Quantifying selection in highthroughput immunoglobulin sequencing data sets. Nucleic Acids Res. 40: e134.
13. Fenwick, M. K., and F. A. Escobedo. 2009. Exploration of factors affecting the onset and maturation course of follicular lymphoma through simulations of the germinal center. Bull. Math. Biol. 71: 1432-1462.
14. Zhu, D., H. McCarthy, C. H. Ottensmeier, P. Johnson, T. J. Hamblin, and F. K. Stevenson. 2002. Acquisition of potential N-glycosylation sites in the immunoglobulin variable region by somatic mutation is a distinctive feature of follicular lymphoma. Blood 99: 2562-2568.
15. Zabalegui, N., A. L. de Cerio, S. Inogés, M. Rodríguez-Calvillo, J. Pérez-Calvo, M. Hernández, J. García-Foncillas, S. Martín-Algarra, E. Rocha, and M. Bendandi. 2004. Acquired potential N-glycosylation sites within the tumor-specific immunoglobulin heavy chains of B-cell malignancies. Haematologica 89: 541-546.
16. McCann, K. J., P. W. Johnson, F. K. Stevenson, and C. H. Ottensmeier. 2006. Universal N-glycosylation sites introduced into the B-cell receptor of follicular lymphoma by somatic mutation: A second tumorigenic event? Leukemia 20: 530-534.
17. Zhu, D., C. H. Ottensmeier, M. Q. Du, H. McCarthy, and F. K. Stevenson. 2003. Incidence of potential glycosylation sites in immunoglobulin variable regions distinguishes between subsets of Burkitt's lymphoma and mucosa-associated lymphoid tissue lymphoma. Br. J. Haematol. 120: 217-222.
18. Hamza, N., H. Bootsma, S. Yuvaraj, F. K. Spijkervet, E. A. Haacke, R. P. Pollard, A. Visser, A. Vissink, C. G. Kallenberg, F. G. Kroese, et al. 2012. Persistence of immunoglobulin-producing cells in parotid salivary glands of patients with primary Sjögren's syndrome after B cell depletion therapy. Ann. Rheum. Dis. 71: 1881-1887.
19. + and CD202 plasma cells in human secondary lymphoid tissue. Blood 109: 4856-4864.
20. Vitali, C., S. Bombardieri, R. Jonsson, H. M. Moutsopoulos, E. L. Alexander, S. E. Carsons, T. E. Daniels, P. C. Fox, R. I. Fox, S. S. Kassan, et al. 2002. Classification criteria for Sjögren's syndrome: A revised version of the European criteria proposed by the American-European Consensus Group. Ann. Rheum. Dis. 61: 554-558.
21. Shiboski, S. C., C. H. Shiboski, L. Criswell, A. Baer, S. Challacombe, H. Lanfranchi, M. Schiødt, H. Umehara, F. Vivino, Y. Zhao, et al. 2012. American College of Rheumatology classification criteria for Sjögren's syndrome: A data-driven, expert consensus approach in the Sjögren's International Collaborative Clinical Alliance cohort. Arthritis Care Res. (Hoboken) 64: 475- 487.
22. Pijpe, J., W. W. Kalk, J. E. van der Wal, A. Vissink, P. M. Kluin, J. L. Roodenburg, H. Bootsma, C. G. Kallenberg, and F. K. Spijkervet. 2007. Parotid gland biopsy compared with labial biopsy in the diagnosis of patients with primary Sjögren's syndrome. Rheumatology (Oxford) 46: 335-341.
23. Kraaijenhagen, H. A. L. 1975. Letter: Technique for parotid biopsy. J. Oral Surg. 33: 328.
24. van Dongen, J. J., A. W. Langerak, M. Brüggemann, P. A. Evans, M. Hummel, F. L. Lavender, E. Delabesse, F. Davi, E. Schuuring, R. García-Sanz, et al. 2003. Design and standardization of PCR primers and protocols for detection of clonal immunoglobulin and T-cell receptor gene recombinations in suspect lymphoproliferations: report of the BIOMED-2 Concerted Action BMH4-CT98-3936. Leukemia 17: 2257-2317.
25. Yuvaraj, S., G. Dijkstra, J. G. Burgerhof, P. M. Dammers, M. Stoel, A. Visser, F. G. Kroese, and N. A. Bos. 2009. Evidence for local expansion of IgA plasma cell precursors in human ileum. J. Immunol. 183: 4871-4878.
26. Giudicelli, V., P. Duroux, C. Ginestoux, G. Folch, J. Jabado-Michaloud, D. Chaume, and M. P. Lefranc. 2006. IMGT/LIGM-DB, the IMGT comprehensive database of immunoglobulin and T cell receptor nucleotide sequences. Nucleic Acids Res. 34: D781-D784.
27. Chen, Z., A. M. Collins, Y. Wang, and B. A. Gaëta. 2010. Clustering-based identification of clonally-related immunoglobulin gene sequence sets. Immunome Res. 6(Suppl. 1): S4.
28. Kasturi, L., H. Chen, and S. H. Shakin-Eshleman. 1997. Regulation of N-linked core glycosylation: use of a site-directed mutagenesis approach to identify Asn- Xaa-Ser/Thr sequons that are poor oligosaccharide acceptors. Biochem. J. 323: 415-419.
29. Balonova, L., L. Hernychova, B. F. Mann, M. Link, Z. Bilkova, M. V. Novotny, and J. Stulik. 2010. Multimethodological approach to identification of glycoproteins from the proteome of Francisella tularensis, an intracellular microorganism. J. Proteome Res. 9: 1995-2005.
30. Good-Jacobson, K. L., C. G. Szumilas, L. Chen, A. H. Sharpe, M. M. Tomayko, and M. J. Shlomchik. 2010. PD-1 regulates germinal center B cell survival and the formation and affinity of long-lived plasma cells. Nat. Immunol. 11: 535- 542.
31. Zuckerman, N. S., H. Hazanov, M. Barak, H. Edelman, S. Hess, H. Shcolnik, D. Dunn-Walters, and R. Mehr. 2010. Somatic hypermutation and antigen-driven selection of B cells are altered in autoimmune diseases. J. Autoimmun. 35: 325- 335.
32. + B cell repertoire in infants. J. Exp. Med. 205: 1331-1342.
33. William, J., C. Euler, S. Christensen, and M. J. Shlomchik. 2002. Evolution of autoantibody responses via somatic hypermutation outside of germinal centers. Science 297: 2066-2070.
34. Schibler, U., K. B. Marcu, and R. P. Perry. 1978. The synthesis and processing of the messenger RNAs specifying heavy and light chain immunoglobulins in MPC-11 cells. Cell 15: 1495-1509.
35. Tengnér, P., A. K. Halse, H. J. Haga, R. Jonsson, and M. Wahren-Herlenius. 1998. Detection of anti-Ro/SSA and anti-La/SSB autoantibody-producing cells in salivary glands from patients with Sjögren's syndrome. Arthritis Rheum. 41: 2238-2248.
36. Dunn-Walters, D., L. Boursier, and J. Spencer. 2000. Effect of somatic hypermutation on potential N-glycosylation sites in human immunoglobulin heavy chain variable regions. Mol. Immunol. 37: 107-113.
37. Coelho, V., S. Krysov, A. M. Ghaemmaghami, M. Emara, K. N. Potter, P. Johnson, G. Packham, L. Martinez-Pomares, and F. K. Stevenson. 2010. Glycosylation of surface Ig creates a functional bridge between human follicular lymphoma and microenvironmental lectins. Proc. Natl. Acad. Sci. USA 107: 18587-18592.
38. Maggi, L., V. Santarlasci, M. Capone, A. Peired, F. Frosali, S. Q. Crome, V. Querci, M. Fambrini, F. Liotta, M. K. Levings, et al. 2010. CD161 is a marker of all human IL-17-producing T-cell subsets and is induced by RORC. Eur. J. Immunol. 40: 2174-2181.
39. Konjević, G., K. Mirjacić Martinović, A. Vuletić, V. Jurisić, and I. Spuzić. 2009. Distribution of several activating and inhibitory receptors on CD32CD16+ NK cells and their correlation with NK cell function in healthy individuals. J. Membr. Biol. 230: 113-123.
40. Robinson, M. J., D. Sancho, E. C. Slack, S. Leibund Gut-Landmann, and C. Reise Sousa. 2006. Myeloid C-type lectins in innate immunity. Nat. Immunol. 7: 1258-1265.
41. Sobral, A. P., M. J. Rego, C. L. Cavalacanti, L. B. Carvalho Jr., and E. I. Beltrão. 2010. ConA and UEA-I lectin histochemistry of parotid gland mucoepidermoid carcinoma. J. Oral Sci. 52: 49-54.
42. Berkowska, M. A., G. J. Driessen, V. Bikos, C. Grosserichter-Wagener, K. Stamatopoulos, A. Cerutti, B. He, K. Biermann, J. F. Lange, M. van der Burg, et al. 2011. Human memory B cells originate from three distinct germinal centerdependent and -independent maturation pathways. Blood 118: 2150-2158.
43. Silverman, G. J., and C. S. Goodyear. 2006. Confounding B-cell defences: lessons from a staphylococcal superantigen. Nat. Rev. Immunol. 6: 465-475.
44. Hillson, J. L., N. S. Karr, I. R. Oppliger, M. Mannik, and E. H. Sasso. 1993. The structural basis of germline-encoded VH3 immunoglobulin binding to staphylococcal protein A. J. Exp. Med. 178: 331-336.
45. Silverman, G. J., P. Roben, J. P. Bouvet, and M. Sasano. 1995. Superantigen properties of a human sialoprotein involved in gut-associated immunity. J. Clin. Invest. 96: 417-426.
46. Youinou, P., Y. L. Pennec, R. Casburn-Budd, M. Dueymes, G. Letoux, and A. Lamour. 1992. Galactose terminating oligosaccharides of IgG in patients with primary Sjögren's syndrome. J. Autoimmun. 5: 393-400.
47. van Timmeren, M. M., B. S. van der Veen, C. A. Stegeman, A. H. Petersen, T. Hellmark, M. Collin, and P. Heeringa. 2010. IgG glycan hydrolysis attenuates ANCA-mediated glomerulonephritis. J. Am. Soc. Nephrol. 21: 1103-1114.
48. Lauc, G., J. E. Huffman, M. Pucić, L. Zgaga, B. Adamczyk, A. Muzinić, M. Novokmet, O. Polasek, O. Gornik, J. Kristić, et al. 2013. Loci associated with N-glycosylation of human immunoglobulin G show pleiotropy with autoimmune diseases and haematological cancers. PLoS Genet. 9: e1003225.
49. Basset, C., V. Durand, C. Jamin, J. Clément, Y. Pennec, P. Youinou, M. Dueymes, and I. M. Roitt. 2000. Increased N-linked glycosylation leading to oversialylation of monomeric immunoglobulin A1 from patients with Sjögren's syndrome. Scand. J. Immunol. 51: 300-306.
50. Basset, C., V. Devauchelle, V. Durand, C. Jamin, Y. L. Pennec, P. Youinou, and M. Dueymes. 1999. Glycosylation of immunoglobulin A influences its receptor binding. Scand. J. Immunol. 50: 572-579.